LYP-8
LYP-8 is a potent and effective NAMPT degrader with maximum degradation of 97% at 0.5 μM in SKOV-3 cells. LYP-8 shows anti-cancer activity in vivo and in vitro (Sturcture Note: (Blue: Cereblon ligand , Black: linker (HY-128801); Pink: Nampt inhibitor Nampt-IN-11 (HY-158689) ).
Product Specifications
UNSPSC
12352005
Target
NAMPT; PROTACs
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease; PROTAC
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/lyp-8.html
Purity
99.89
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CC1=C(SC=N1)C2=CC=C(C=C2)[C@@H](NC([C@@H]3C[C@H](CN3C([C@H](C(C)(C)C)NC(COCCOCCOCCNC(C4=CC=C(C=C4)C(N5CCC(CC5)CCCCNC(/C=C/C6=CN=CC=C6)=O)=O)=O)=O)=O)O)=O)C
Molecular Formula
C56H74N8O10S
Molecular Weight
1051.30
References & Citations
[1]Lu T, et al. Design of FK866-Based Degraders for Blocking the Nonenzymatic Functions of Nicotinamide Phosphoribosyltransferase. J Med Chem. 2024;67 (10) :8099-8121.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
KN415827 1 Kit
Salivary alpha amylase (AMY1C) Human Gene Knockout Kit (CRISPR)
Sign In for Pricing
View Details 
BNC883450-100 1x 100 µL
Alpha Actinin 4 / ACTN4 (93), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC741492-500 1x 500 µL
PAX8 (Renal Cell Marker) (PAX8/1492), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 